(Q34515636)

2 August 2017

1 reference

title

Evolving pathophysiologic concepts in nonalcoholic steatohepatitis (English)

1 reference

2 August 2017

0 references

1 reference

Brent A Neuschwander-Tetri

series ordinal

1

1 reference

2 August 2017

publication date

1 February 2002

1 reference

Current gastroenterology reports

2 August 2017

published in

1 reference

2 August 2017

volume

4

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

31-36

1 reference

Role of insulin in hepatic fatty acid partitioning: emerging concepts

2 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11894-002-0035-X

Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11894-002-0035-X

Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease

21 January 2018

1 reference

12 December 2020

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

12 December 2020

Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients.

1 reference

12 December 2020

Liver biopsy interpretation for the gastroenterologist

1 reference

12 December 2020

Surgical removal of visceral fat reverses hepatic insulin resistance.

1 reference

12 December 2020

Considerations on the pathogenesis of fatty liver

1 reference

12 December 2020

Nonalcoholic steatohepatitis: An expanded clinical entity

1 reference

12 December 2020

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

1 reference

12 December 2020

Closing in on the signals of hepatic fibrosis

1 reference

12 December 2020

New perspectives into the molecular pathogenesis and treatment of type 2 diabetes

1 reference

12 December 2020

Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein

1 reference

12 December 2020

Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells

1 reference

12 December 2020

Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity

1 reference

12 December 2020

Treatment of nonalcoholic fatty liver: present and emerging therapies

1 reference

12 December 2020

Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells

1 reference

12 December 2020

Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.

1 reference

12 December 2020

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

1 reference

12 December 2020

Hyperinsulinemia and insulin resistance in non-alcoholic steatohepatitis.

1 reference

12 December 2020

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

1 reference

12 December 2020

Idiopathic steatohepatitis in childhood: a multicenter retrospective study

1 reference

12 December 2020

Dyslipidemia of central obesity and insulin resistance.

1 reference

12 December 2020

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

12 December 2020

The hormone resistin links obesity to diabetes

1 reference

12 December 2020

Nonalcoholic steatohepatitis: definition and pathology

1 reference

12 December 2020

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

1 reference

12 December 2020

1 reference

12 December 2020

Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma

1 reference

12 December 2020

The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease

1 reference

12 December 2020

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

1 reference

12 December 2020

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene

1 reference

12 December 2020

Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study

1 reference

12 December 2020

Liver morphology in morbid obesity: a literature study

1 reference

12 December 2020

Clinical features and natural history of nonalcoholic steatosis syndromes

1 reference

12 December 2020

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

12 December 2020

Subcapsular steatonecrosis in response to peritoneal insulin delivery: a clue to the pathogenesis of steatonecrosis in obesity

1 reference

12 December 2020

PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes

1 reference

12 December 2020

Imaging of hepatic steatosis

1 reference

12 December 2020

1 reference

12 December 2020

Regulation of VLDL synthesis and secretion in the liver.

1 reference

12 December 2020

Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis

1 reference

12 December 2020

Persistent hyperaminotransferasemia resolving after weight reduction in obese children

1 reference

12 December 2020

Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver

1 reference

12 December 2020

Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action

1 reference

12 December 2020

Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction

1 reference

12 December 2020

10.1007/S11894-002-0035-X

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1046800983

0 references

1 reference